Jardón-Reyes A, Hernández-Amaro H, Hernández-Torres G, Devesa-Gutiérrez I

Language: Spanish
References: 25
Page: 354-359
PDF size: 838.49 Kb.

ABSTRACT

Background: The diabetic neuropathy is the most common microvascular complication of diabetes mellitus. The reported prevalence ranges from 10-90%. Electrophysiological alterations can be demonstrated in nearly 100% of diabetics.
Objective: To know the current profile of the patient with diabetic polyneuropathy.
Methods: Retrospective and descriptive study from 2015 to 2016. Reports of electroneuromyography with diabetic polyneuropathy result were analyzed, evaluating neuroconduction parameters of motor and sensory nerves, late F responses and myography. Descriptive statistics, Student's t-test and Pearson's correlation coefficient were used.
Results: The sample included 72 men (65.5%) and 38 women (34.5%), mean age 61.2 years, mean duration of diabetes of 9.9 years. The most affected nerve was superficial peroneus, absent in 70% of the population. A positive correlation was found (p ‹0.001) for the affection of all the nerves symmetrically and predominantly in neuroconduction velocities of the lower and upper limbs.
Conclusion: The most frequent electrophysiological finding in diabetic polyneuropathy was sensory affection, being more severe in lower limbs. A finding in patients with recent diagnosis is the prolongation of proximal latencies in the lower extremities.

REFERENCES

1. Organización Mundial de la Salud. Diabetes. Nota Descriptiva. Ginebra, Suiza: OMS; 2012.

2. World Health Organization. Global data on visual impairments 2010-2012. Geneve, Switzerland: WHO. 2016.

3. Hernández-Ávila M, Gutiérrez J, Reynoso-Noverón N. Diabetes mellitus en México. El estado de la epidemia. Salud Publica Mex. 2013;55(1):129-36.

4. Martinez-Conde A, Paredes-Fernandez C, Zacarias-Castillo R. Neuropatía diabética. Rev Hosp Gral Dr M Gea González. 2002;5(1 y 2):7-23.

5. Samper-Bernal D, Monerris-Tabasco MM, Homs-Riera M, Soler-Pedrola M. Etiología y manejo de la neuropata diaébtica dolorosa. Rev la Soc Esp del Dolor. 2010;17(6):286-96.

6. Feldman EL, Russell JW, Sullivan KA, Golovoy D. New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neuro. 1999;12(5):553-563.

7. Tesfaye S, Selvarajah D. The Eurodiab study: what has this taught us about diabetic peripheral neuropathy? Curr Diab Rep. 2009;9(6):432-4.

8. Rota E, Quadri R, Fanti E, Isoardo G, Poglio F, Tavella A, et al. Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus. J Peripher Nerv. 2005;10(4):348-53.

9. Klein R, Klein BE Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann of Internal Medicine. 2005;124(1 Pt 2):90-5. 2

10. Valls-Canals J, Povedano M, Montero J, Pradas J. Diabetic polyneuropathy. Axonal or demyelinating? Electromyogr Clin Neurophysiol. 6;42(1):3-6.

11. Albers JW, Brown MB, Sima AA. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group for Edit (Early Diabetes Intervention Trial). Muscle Nerve. 1996;19:140-146.

12. Perkins B, Bril V. Electrophysiologic testing in diabetic neuropathy. Handb Clin Neurol. 2014;126:235-48.

13. Preston DC, Shapiro B. Electromyography and Neuromuscular Disorders: Clinical Electrophysiologic Correlations. Elsevier; 2005. 368 p.

14. Mondelli M, Aretini A, Baldasseroni A. Distal symmetric polyneuropathy in diabetes. Differences between patients with and without neuropathic pain. Exp Clin Endocrinol Diabetes. 2012;120(1):45-50.

15. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1977;40(11):1072-82.

16. Thomas PK. Peripheral neuropathy. 2nd ed. Dyck PJ, Thomas PK, Lambert EH, Editor. Philadelphia: WB Saunders; 1984.

17. Valls-Canals J, Povedano M, Montero J, Pradas J. Diabetic polyneuropathy. Axonal or demyelinating? Electromyogr Clin Neurophysiol. 2002;42(1):3-6.

18. Ratzmann KP, Raschke M, Gander I, Schimke E. Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. J Diabetes Complicat. 1991;5(1):1-5.

19. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60(1):108-11.

20. Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001;24(9):1229-31.

21. Hsu WC, Chiu YH, Chen WH, Chiu HC, Liou HH, Chen Th. Simplified electrodiagnostic criteria of diabetic polyneuropathy in field study (KCIS No. 14). Neuroepidemiology. 2007;28(1):50-5.

22. Vinik AI, Kong X, Megerian JT, Gozani SN. Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol Ther. 2006;8(6):654-62.

23. Liu MS, Hu BL, Cui LY, Tang XF, Du H, Li BH. [Clinical and neurophysiological features of 700 patients with diabetic peripheral neuropathy]. Zhonghua Nei Ke Za Zhi. 2005;44(3):173-6. 4

24. Andersen H, Stålberg E, Falck B. F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve. 1997;20(10):1296-302.

25. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, Takiguchi M, et al. F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia. 2000;43(7):915-21.